Earnings Call · Q1 FY2026·2026-05-08

Q1 26EPS +6.25%·Rev n/aQ4 25EPS -35.53%·Rev n/aQ3 25EPS +38.75%·Rev n/aQ2 25EPS +60.00%·Rev n/a⚠ consensus missing

Arcturus Therapeutics Holdings Inc. ARCT

Neda Safarzadeh — Vice President, Head of Investor Relations

Joseph Payne — President and CEO

Alan Cohen — Chief Medical Officer

Dennis M. Mulroy — Chief Financial Officer

+3.6%1d on move date+2.8% vs SPY3d−7.3%5d−12.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARCT calls or request research access.

More ARCT calls Browse calls Request research access